Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash to Debt 0.06
OMCM's Cash to Debt is ranked lower than
60% of the 2078 Companies
in the Global Health Information Services industry.

( Industry Median: 5.21 vs. OMCM: 0.06 )
OMCM' s 10-Year Cash to Debt Range
Min: 0   Max: No Debt
Current: 0.06

Equity to Asset -5.20
OMCM's Equity to Asset is ranked lower than
61% of the 2008 Companies
in the Global Health Information Services industry.

( Industry Median: 0.60 vs. OMCM: -5.20 )
OMCM' s 10-Year Equity to Asset Range
Min: -17.38   Max: -0.05
Current: -5.2

-17.38
-0.05
F-Score: 4
Z-Score: -14.72
M-Score: -3.80
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating margin (%) -15.58
OMCM's Operating margin (%) is ranked lower than
51% of the 2062 Companies
in the Global Health Information Services industry.

( Industry Median: 5.48 vs. OMCM: -15.58 )
OMCM' s 10-Year Operating margin (%) Range
Min: -8416.9   Max: 3.86
Current: -15.58

-8416.9
3.86
Net-margin (%) 11.19
OMCM's Net-margin (%) is ranked higher than
87% of the 2062 Companies
in the Global Health Information Services industry.

( Industry Median: 3.74 vs. OMCM: 11.19 )
OMCM' s 10-Year Net-margin (%) Range
Min: -8545.07   Max: -22.06
Current: 11.19

-8545.07
-22.06
ROA (%) 34.10
OMCM's ROA (%) is ranked higher than
99% of the 2086 Companies
in the Global Health Information Services industry.

( Industry Median: 3.75 vs. OMCM: 34.10 )
OMCM' s 10-Year ROA (%) Range
Min: -978.32   Max: -62.82
Current: 34.1

-978.32
-62.82
ROC (Joel Greenblatt) (%) -459.67
OMCM's ROC (Joel Greenblatt) (%) is ranked lower than
56% of the 2071 Companies
in the Global Health Information Services industry.

( Industry Median: 28.79 vs. OMCM: -459.67 )
OMCM' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -4027.27   Max: 96.15
Current: -459.67

-4027.27
96.15
Revenue Growth (3Y)(%) 2.20
OMCM's Revenue Growth (3Y)(%) is ranked higher than
64% of the 1669 Companies
in the Global Health Information Services industry.

( Industry Median: 5.60 vs. OMCM: 2.20 )
OMCM' s 10-Year Revenue Growth (3Y)(%) Range
Min: -58.1   Max: 81.7
Current: 2.2

-58.1
81.7
EBITDA Growth (3Y)(%) -100.00
OMCM's EBITDA Growth (3Y)(%) is ranked lower than
57% of the 1370 Companies
in the Global Health Information Services industry.

( Industry Median: 7.20 vs. OMCM: -100.00 )
OMCM' s 10-Year EBITDA Growth (3Y)(%) Range
Min: -100   Max: 21.6
Current: -100

-100
21.6
» OMCM's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with OMCM

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 15.70
OMCM's P/E(ttm) is ranked higher than
89% of the 2271 Companies
in the Global Health Information Services industry.

( Industry Median: 58.20 vs. OMCM: 15.70 )
OMCM' s 10-Year P/E(ttm) Range
Min: 6.46   Max: 15.71
Current: 15.7

6.46
15.71
P/S 1.22
OMCM's P/S is ranked higher than
80% of the 2271 Companies
in the Global Health Information Services industry.

( Industry Median: 2.60 vs. OMCM: 1.22 )
OMCM' s 10-Year P/S Range
Min: 0.19   Max: 10.14
Current: 1.22

0.19
10.14
EV-to-EBIT -16.09
OMCM's EV-to-EBIT is ranked lower than
54% of the 2271 Companies
in the Global Health Information Services industry.

( Industry Median: 34.56 vs. OMCM: -16.09 )
OMCM' s 10-Year EV-to-EBIT Range
Min: -1647.3   Max: 77.6
Current: -16.09

-1647.3
77.6
Current Ratio 0.24
OMCM's Current Ratio is ranked lower than
61% of the 2043 Companies
in the Global Health Information Services industry.

( Industry Median: 1.91 vs. OMCM: 0.24 )
OMCM' s 10-Year Current Ratio Range
Min: 0.02   Max: 0.98
Current: 0.24

0.02
0.98
Quick Ratio 0.24
OMCM's Quick Ratio is ranked lower than
61% of the 2043 Companies
in the Global Health Information Services industry.

( Industry Median: 1.78 vs. OMCM: 0.24 )
OMCM' s 10-Year Quick Ratio Range
Min: 0.02   Max: 0.98
Current: 0.24

0.02
0.98

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 0.60
OMCM's Price/Median PS Value is ranked higher than
94% of the 2271 Companies
in the Global Health Information Services industry.

( Industry Median: 1.18 vs. OMCM: 0.60 )
OMCM' s 10-Year Price/Median PS Value Range
Min: 0.14   Max: 100
Current: 0.6

0.14
100
Earnings Yield (Greenblatt) -6.20
OMCM's Earnings Yield (Greenblatt) is ranked lower than
52% of the 2056 Companies
in the Global Health Information Services industry.

( Industry Median: 3.80 vs. OMCM: -6.20 )
OMCM' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.3   Max: 5.6
Current: -6.2

1.3
5.6

Business Description

Industry: Application Software » Health Information Services
Compare: » details
Omnicomm Systems Inc was incorporated on February 17, 1999. The Company provides web-based electronic data capture and eClinical software and services for the clinical research process. Its eClinical software and service offerings include TrialMaster, TrialOne and eClinical Suite, Promasys. Its eClinical Products are designed to allow clinical trial sponsors and investigative sites to easily and securely collect, validate, transmit, and analyze clinical study data. The eClinical Products are 21 CFR Part 11 compliant solutions and are designed to offer clinical trial sponsors the ability to conduct clinical trials under multiple platforms, with significant flexibility, ease-of-use and with complete control over collected data. The Company also provides business process consulting services that focus on more effectively integrating EDC and eClinical Solutions and processes into the clinical trial process.Its customers include pharmaceutical, biotechnology, medical device companies, academic institutions, clinical research organizations and other entities engaged in clinical trials. The Company competes with systems and paper-based processes utilized by existing or prospective customers, as well as other commercial vendors of EDC and eClinical applications, clinical data management systems and adverse event reporting software The conduct of clinical trials is subject to regulation and regulatory guidance associated with the approval of new drugs, biological products and medical devices imposed upon the clinical trial process by the U.S. federal government and related regulatory authorities such as the U.S. Food and Drug Administration, or FDA, and by foreign governments.
» More Articles for OTCBB:OMCM

Headlines

Articles On GuruFocus.com
OmniComm Systems(R) Recognizes Excellence in Clinical Research and Development at Innovation Forum 2 Dec 19 2014 
OmniComm Systems(R) Announces 135% YOY Growth in Total Contract Value Through Q3 2014 Nov 26 2014 
Larix, Denmark's Full Service Contract Research Organization, Selects OmniComm's(R) TrialMaster(R) E Nov 20 2014 
Belgian Contract Research Organization, Business & Decision Life Sciences, Partners With OmniComm Sy Oct 28 2014 
Top 10 Pharmaceutical Company Moves to OmniComm Systems'(R) OmniCloud(R) Oct 20 2014 

More From Other Websites
OmniComm Systems(R) Recognizes Excellence in Clinical Research and Development at Innovation Forum... Dec 19 2014
Merge Healthcare (MRGE) Worth Watching: Stock Gains 6.5% Dec 04 2014
OMNICOMM SYSTEMS INC Files SEC form 8-K, Other Events Nov 26 2014
OmniComm Systems(R) Announces 135% YOY Growth in Total Contract Value Through Q3 2014 Nov 26 2014
OMNICOMM SYSTEMS INC Financials Nov 21 2014
Larix, Denmark's Full Service Contract Research Organization, Selects OmniComm's(R) TrialMaster(R)... Nov 20 2014
10-Q for OmniComm Systems, Inc. Nov 14 2014
OMNICOMM SYSTEMS INC Files SEC form 10-Q, Quarterly Report Nov 12 2014
Belgian Contract Research Organization, Business & Decision Life Sciences, Partners With OmniComm... Oct 28 2014
OMNICOMM SYSTEMS INC Files SEC form 8-K/A, Financial Statements and Exhibits Oct 23 2014
Top 10 Pharmaceutical Company Moves to OmniComm Systems'(R) OmniCloud(R) Oct 20 2014
Leading In Vitro Diagnostics Company Selects OmniComm's(R) TrialMaster(R) Electronic Data Capture... Sep 17 2014
OMNICOMM SYSTEMS INC Files SEC form 10-Q/A, Quarterly Report Sep 08 2014
OMNICOMM SYSTEMS INC Files SEC form 10-K/A, Annual Report Sep 08 2014
OmniComm Systems(R) Announces Record Contract Growth in First Half of 2014 Aug 18 2014
OMNICOMM SYSTEMS INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets,... Aug 14 2014
OMNICOMM SYSTEMS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Aug 04 2014
TFS, Top Sweden-Based Contract Research Organization, Selects OmniComm(R) TrialMaster(R) for Global... Jul 21 2014
Leading Biotechnology Company Selects OmniComm Systems'(R) TrialMaster(R) Jul 07 2014
OmniComm Systems(R) Signs Multi-Year Agreement With Top 5 Global CRO for TrialOne(R) Jun 25 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK